GlassScriptPhysician profile
Michael Hughes
NPI 1447786173
$1,819.07
in general payments reported to CMS, 2019-2025
12 companies · $444 in 2025
The $444 reported for 2025 was more than what 78% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.85 · 2022: $136 · 2023: $423 · 2024: $801 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,667.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $854.86 | 2023-2025 | Embold Fibered, Therasphere Y90 Glass Microspheres 10 Gbq, General - Embolics |
| Terumo Medical Corporation | $293.36 | 2022-2024 | Azur Cx Detachable |
| Stryker Corporation | $146.79 | 2025 | Clottriever Bold Catheter |
| Inari Medical, INC. | $146.38 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $127.54 | 2023-2024 | Concertotm, Endurant Iis, Emprint |
| Asahi Intecc USA, INC. | $86.02 | 2024-2025 | Peripheral Vascular, Asahi Interventional Radiology Wires |
| Ge Healthcare | $57.14 | 2024 | |
| Tersera Therapeutics LLC | $32.22 | 2025 | Xermelo |
| Becton, Dickinson and Company | $21.32 | 2024 | Lutonix Drug Coated Balloon |
| Cardiva Medical, INC. | $19.72 | 2023 | Cardiva Vascade 6/7f Vcs |
| Trisalus Life Sciences, INC. | $17.87 | 2025 | Trinav Infusion System |
| Lilly USA, LLC | $15.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.